{"id":"https://openalex.org/W183595628","doi":null,"title":"[Aliskiren combined with losartan in type 2-diabetes and nephropathy - secondary publication].","display_name":"[Aliskiren combined with losartan in type 2-diabetes and nephropathy - secondary publication].","publication_year":2009,"publication_date":"2009-03-09","ids":{"openalex":"https://openalex.org/W183595628","mag":"183595628","pmid":"https://pubmed.ncbi.nlm.nih.gov/19291865"},"language":"da","primary_location":{"id":"pmid:19291865","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19291865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ugeskrift for laeger","raw_type":"English Abstract"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111749912","display_name":"Hans\u2010Henrik Parving","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]},{"id":"https://openalex.org/I4405271615","display_name":"Steno Diabetes Center Aarhus","ror":"https://ror.org/02qwvry66","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4405271615"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Hans-Henrik Parving","raw_affiliation_strings":["Aarhus Universitet, Det Sundhedsvidenskabelige Fakultet, Steno Diabetes Center. hhparving@dadlnet.dk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aarhus Universitet, Det Sundhedsvidenskabelige Fakultet, Steno Diabetes Center. hhparving@dadlnet.dk","institution_ids":["https://openalex.org/I204337017","https://openalex.org/I4405271615"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012676820","display_name":"Frederik Persson","orcid":"https://orcid.org/0000-0001-6242-6638","observed_orcids":["https://orcid.org/0000-0001-6242-6638","https://orcid.org/0000-0002-5019-4312"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederik Persson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055479743","display_name":"Julia Breyer Lewis","orcid":"https://orcid.org/0000-0002-1530-7115","observed_orcids":["https://orcid.org/0000-0002-1530-7115"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia B Lewis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048492705","display_name":"Edmund J. Lewis","orcid":"https://orcid.org/0009-0001-0323-3083","observed_orcids":["https://orcid.org/0009-0001-0323-3083"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edmund J Lewis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113527981","display_name":"Norman K. Hollenberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norman K Hollenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6887,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.74228037,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"171","issue":"11","first_page":"881","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.013500000350177288,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aliskiren","display_name":"aliskiren","score":1.0},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9169999957084656},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9950000047683716},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.9120000004768372},{"id":"https://openalex.org/keywords/urinary-albumin-creatinine-ratio","display_name":"urinary albumin-creatinine ratio","score":0.9559999704360962},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7829999923706055},{"id":"https://openalex.org/keywords/ace2-inhibition","display_name":"ACE2 inhibition","score":0.41600000858306885},{"id":"https://openalex.org/keywords/combination-antihypertensive-therapy","display_name":"combination antihypertensive therapy","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C2779838083","wikidata":"https://www.wikidata.org/wiki/Q414904","display_name":"Aliskiren","level":4,"score":0.9410442113876343},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.9115132093429565},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7846254110336304},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.7356175184249878},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.6723243594169617},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6510999202728271},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.6109654307365417},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5813281536102295},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5034372210502625},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.47719892859458923},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47492700815200806},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.4488416910171509},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.432700514793396},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.39688125252723694},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.23466706275939941},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.19675055146217346},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"pmid:19291865","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19291865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ugeskrift for laeger","raw_type":"English Abstract"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/c141b800-89c0-11df-928f-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/c141b800-89c0-11df-928f-000ea68e967b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Parving, H-H, Persson, F, Lewis, J B, Lewis, E J & Hollenberg, N K 2009, 'Aliskiren combined with losartan in type 2-diabetes and nephropathy - secondary publication', Ugeskrift for l\u00e6ger, vol. 171, no. 11, pp. 881-884.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/d9bc54d0-6a3a-11df-928f-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/d9bc54d0-6a3a-11df-928f-000ea68e967b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Parving, H-H, Persson, F, Lewis, J B, Lewis, E J & Hollenberg, N K 2009, 'Kombination af aliskiren og losartan hos patienter med type 2-diabetes og nefropati - Sekundaerpublikation', Ugeskrift for l\u00e6ger, bind 171, nr. 11, s. 881-4.","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:183595628","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19291865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2145632481","https://openalex.org/W2036234436","https://openalex.org/W2186876583","https://openalex.org/W2777913927","https://openalex.org/W2035357682","https://openalex.org/W4244535723","https://openalex.org/W2045198428","https://openalex.org/W2010407705","https://openalex.org/W2118795730","https://openalex.org/W7098389766"],"abstract_inverted_index":{"We":[0],"evaluated":[1],"the":[2,54,63],"renoprotective":[3,87],"effects":[4],"of":[5,23,31,78,89],"adding":[6],"aliskiren":[7,36],"to":[8,28,39],"treatment":[9,32],"with":[10,15,33,74],"losartan":[11,40],"in":[12,37,53],"hypertensive":[13],"patients":[14,25],"type":[16],"2":[17],"diabetes":[18],"and":[19,43],"nephropathy.":[20],"A":[21],"total":[22],"599":[24],"were":[26],"randomized":[27],"six":[29],"months":[30],"placebo":[34],"or":[35],"addition":[38],"100":[41],"mg":[42,60],"optimal":[44],"antihypertensive":[45],"therapy.":[46],"The":[47,76],"primary":[48],"outcome":[49],"was":[50,81],"a":[51],"reduction":[52],"urinary":[55,65],"albumin-creatinine":[56,66],"ratio.":[57],"Aliskiren":[58,85],"300":[59],"daily":[61],"reduced":[62],"mean":[64],"ratio":[67],"by":[68],"20%":[69],"(p":[70],"<":[71],"0.001)":[72],"compared":[73],"placebo.":[75],"number":[77],"adverse":[79],"events":[80],"similar":[82],"between":[83],"groups.":[84],"is":[86],"independently":[88],"its":[90],"blood":[91],"pressure":[92],"lowering":[93],"effect.":[94]},"counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}